I want to thank [CEO Vas Narasimhan] for the opportunity to work at this great company and to everyone in oncology for their commitment to transforming cancer for patients and their families.

Novartis’ head of drug development Vas Narasimhan talks about the company’s stake in CAR-T immunotherapy. These cell therapies are set to transform treatment of blood cancers – but questions ...

If you’re aiming to have more family movie nights this year, then you need to know the best family movies on Netflix right now. It’s much easier to cut to the chase with this list rather than ...

Speaking with members of the media on Friday, Narasimhan said the "FDA no longer deemed it necessary to hold an advisory committee meeting." "We think it's based on, you know, the overall data ...

February 12, 2025 • How the criminal legal system considers who is and isn't Native, and what that means for the Black people who are members of tribal nations. This reporting is part of an ...

Novartis CEO 'very confident' on sales target, doesn't fear patent cliff Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an interview ...

Cute animated tale with some mild peril and scary bugs.

How do you feel today about VAS?